Valirx
VAL · AIM · Health Care · mcap £1.8m · 0.1p
Financials · LTM to 30 Jun 26
Source: results 15 Sep 26 ↗
Going-concern uncertainty
- Revenue
- £33k
- Operating profit
- −£2.3m
- Net income
- −£2.1m
- Free cash flow
- −£1.4m
- Net cash
- £971k
- Market cap
- £1.8m
- EV / EBIT
- –
- FCF yield
- −76.3%
- Price / book
- 0.7×
Latest half-year · H1 26 vs H1 25
results 15 Sep 26 ↗
- Revenue
- £1k prior £0k
- Operating profit
- −£821k prior −£934k
- Net income
- −£746k prior −£838k
- Cash from operations
- −£840k prior −£994k
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Latest report: H1 26 (six months to 30 Jun 26), published 15 Sep 26 · read the results ↗
£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source
| LTM Jun 26 | FY 25 | |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Gross profit | (0.0) | (0.0) |
| Operating profit | (2.3) | (2.4) |
| Depreciation (owned assets) | 0.1 | 0.1 |
| Finance costs | (0.0) | (0.0) |
| Profit before tax | (2.3) | (2.4) |
| Tax | 0.1 | 0.1 |
| Net income (owners) | (2.1) | (2.2) |
| EPS basic | (0.4p) | (0.5p) |
| H1 26 | vs H1 25 | H2 25 | H1 25 | |
|---|---|---|---|---|
| Revenue | 0.0 | n/m | 0.0 | 0.0 |
| Gross profit | 0.0 | n/m | (0.0) | 0.0 |
| Operating profit | (0.8) | n/m | (1.5) | (0.9) |
| Depreciation (owned assets) | 0.0 | n/m | 0.0 | 0.0 |
| Finance costs | (0.0) | n/m | (0.0) | (0.0) |
| Profit before tax | (0.8) | n/m | (1.5) | (0.9) |
| Tax | 0.1 | n/m | 0.1 | 0.1 |
| Net income (owners) | (0.7) | n/m | (1.4) | (0.8) |
| EPS basic | (0.1p) | – | (0.3p) | (0.2p) |
| LTM Jun 26 | FY 25 | |
|---|---|---|
| Cash from operations | (1.4) | (1.5) |
| Interest paid | (0.0) | (0.0) |
| Capex (PP&E) | (0.0) | (0.0) |
| Shares issued | 2.1 | 0.9 |
| Latest Jun 26 | FY 25 | |
|---|---|---|
| Goodwill | 1.0 | 1.0 |
| Other intangibles | 0.3 | 0.4 |
| Property, plant & equipment | 0.1 | 0.1 |
| Other investments | 0.0 | 0.0 |
| Inventories | 0.1 | 0.1 |
| Trade receivables | 0.1 | 0.1 |
| Cash | 1.0 | 0.8 |
| Total assets | 2.8 | 2.6 |
| Trade payables | 0.1 | 0.2 |
| Borrowings, current | 0.0 | 0.0 |
| Total liabilities | 0.1 | 0.2 |
| Non-controlling interests | (0.5) | (0.5) |
| Total equity | 2.6 | 2.4 |
| H1 26 | H2 25 | H1 25 | |
|---|---|---|---|
| Goodwill | 1.0 | 1.0 | 1.6 |
| Other intangibles | 0.3 | 0.4 | 0.5 |
| Property, plant & equipment | 0.1 | 0.1 | 0.2 |
| Other investments | 0.0 | 0.0 | 0.0 |
| Inventories | 0.1 | 0.1 | 0.1 |
| Trade receivables | 0.1 | 0.1 | 0.1 |
| Cash | 1.0 | 0.8 | 0.5 |
| Total assets | 2.8 | 2.6 | 3.1 |
| Trade payables | 0.1 | 0.2 | 0.1 |
| Borrowings, current | 0.0 | 0.0 | 0.0 |
| Total liabilities | 0.1 | 0.2 | 0.1 |
| Non-controlling interests | (0.5) | (0.5) | (0.4) |
| Total equity | 2.6 | 2.4 | 3.0 |
Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.
Company filings. Not investment advice.